Work

Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches

Year: 2022

Type: review

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.06.013

Authors: F. Cortiula, B. Reymen, S. Peters, P. Van Mol, E. Wauters, J. Vansteenkiste, D. De Ruysscher, L.E.L. Hendriks

Institutions: University of Udine, Maastricht University Medical Centre, Maastro Clinic, Centre Hospitalier Universitaire Vaudois, KU Leuven, Universitair Ziekenhuis Leuven

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, AstraZeneca, European Society for Medical Oncology, Genentech

OpenAlex ID: W4283696256

FWCI: 2.692

Cites: 121

Cited by: 100

Related to: 10